Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy
Clinical trial NCT02075255 · COMPLETED
Trial details
- NCT number
- NCT02075255
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-28
- Primary completion
- 2016-08-08
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.